Embr Labs Awarded Six Patents for AI-driven Digital Therapeutics
CardioSignal Presents a New Clinical Modality for Heart Failure Detection Using Smartphones
FDA Clears First AI to Aid Heart Failure Detection During Routine Check-Ups
This Innovative Wearable Is Aiming to Combat Rock & Roll’s Legacy of Hearing Loss
Cleerly Receives FDA Breakthrough Device Designation for Heart Disease Risk Staging System
CardioSignal Raises $10 Million in Series A
Ciba Health Raises $10M for its Integrated Care Platform
Washington Post | Scientists May Have the Key to Treating Tinnitus
Embr Publishes Data on Ability to Address Hot Flashes in Men Undergoing Prostate Cancer Treatment
SENSORA AI Algorithm was Demonstrated to be Twice as Accurate at Detecting Structural Heart Disease When Compared to the Standard of Care.
Tali AI, The Leading AI Medical Scribe Provider, Announces Significant Funding to Combat Physician Burnout
Embr Labs Appoints New Strategic Board Members
FIGUR8, the market leader for measuring musculoskeletal (MSK) health and injury recovery, secures $25M Series A-1 financing
FIGS and Eko Health Collaborate on the FIGS | Eko CORE 500™ Digital Stethoscope
Eko Named to 2022 CB Insights Digital Health 150
Fixing the System: How StrivePD Shifts the Burden of Care off People with Parkinson’s and Empowers Clinicians to Improve Care
Introducing StriveStudy: Rune Labs’ New Clinical Trial Platform to Accelerate the Development of Precision Neurology Therapies
StrivePD: Empowering Parkinson's Patients with Personalized Insights
BlueRock Therapeutics to Use Rune Labs' Clinical Trial Platform to Better Characterize Parkinson's Disease State in Cell Therapy Trials
Eko Health Launches CORE 500™ Digital Stethoscope with Heart Disease Detection AI
